Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial

Wensi Zhao, Shaobo Ke, Xiaojun Cai, Zhigang Zuo, Wei Shi, Hu Qiu, Gaoke Cai, Yi Gong, Yong Wu, Shasha Ruan, Yongshun Chen